These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34327673)

  • 1. Data-Driven Subgroup Identification in Confirmatory Clinical Trials.
    Bunouf P; Groc M; Dmitrienko A; Lipkovich I
    Ther Innov Regul Sci; 2022 Jan; 56(1):65-75. PubMed ID: 34327673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplicity considerations in subgroup analysis.
    Dmitrienko A; Millen B; Lipkovich I
    Stat Med; 2017 Dec; 36(28):4446-4454. PubMed ID: 28762525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplicity issues in exploratory subgroup analysis.
    Lipkovich I; Dmitrienko A; Muysers C; Ratitch B
    J Biopharm Stat; 2018; 28(1):63-81. PubMed ID: 29173045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials.
    Dmitrienko A; Muysers C; Fritsch A; Lipkovich I
    J Biopharm Stat; 2016; 26(1):71-98. PubMed ID: 26366479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials.
    Lipkovich I; Dmitrienko A; B R
    Stat Med; 2017 Jan; 36(1):136-196. PubMed ID: 27488683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup analysis and interpretation for phase 3 confirmatory trials: White paper of the EFSPI/PSI working group on subgroup analysis.
    Dane A; Spencer A; Rosenkranz G; Lipkovich I; Parke T;
    Pharm Stat; 2019 Mar; 18(2):126-139. PubMed ID: 30592133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recursive partitioning approach for subgroup identification in individual patient data meta-analysis.
    Mistry D; Stallard N; Underwood M
    Stat Med; 2018 Apr; 37(9):1550-1561. PubMed ID: 29383818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model-Based Recursive Partitioning for Subgroup Analyses.
    Seibold H; Zeileis A; Hothorn T
    Int J Biostat; 2016 May; 12(1):45-63. PubMed ID: 27227717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subgroup identification based on differential effect search--a recursive partitioning method for establishing response to treatment in patient subpopulations.
    Lipkovich I; Dmitrienko A; Denne J; Enas G
    Stat Med; 2011 Sep; 30(21):2601-21. PubMed ID: 21786278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subgroup identification using covariate-adjusted interaction trees.
    Steingrimsson JA; Yang J
    Stat Med; 2019 Sep; 38(21):3974-3984. PubMed ID: 31162690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations.
    Huber C; Benda N; Friede T
    Pharm Stat; 2019 Oct; 18(5):600-626. PubMed ID: 31270933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
    Hemmings R
    J Biopharm Stat; 2014; 24(1):4-18. PubMed ID: 24392975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials.
    Alosh M; Huque MF; Bretz F; D'Agostino RB
    Stat Med; 2017 Apr; 36(8):1334-1360. PubMed ID: 27891631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible Bayesian subgroup analysis in early and confirmatory trials.
    Bunn V; Liu R; Lin J; Lin J
    Contemp Clin Trials; 2020 Nov; 98():106149. PubMed ID: 32942055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AN OMNIBUS TEST FOR DETECTION OF SUBGROUP TREATMENT EFFECTS VIA DATA PARTITIONING.
    Sun Y; He X; Hu J
    Ann Appl Stat; 2022 Dec; 16(4):2266-2278. PubMed ID: 37521002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subgroup identification in dose-finding trials via model-based recursive partitioning.
    Thomas M; Bornkamp B; Seibold H
    Stat Med; 2018 May; 37(10):1608-1624. PubMed ID: 29388228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Homogeneous Subgroups in Neurological Disorders: Unbiased Recursive Partitioning in Cervical Complete Spinal Cord Injury.
    Tanadini LG; Steeves JD; Hothorn T; Abel R; Maier D; Schubert M; Weidner N; Rupp R; Curt A
    Neurorehabil Neural Repair; 2014 Jul; 28(6):507-15. PubMed ID: 24477680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES.
    Lipkovich I; Dmitrienko A
    J Biopharm Stat; 2014; 24(1):130-53. PubMed ID: 24392982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Q-Finder: An Algorithm for Credible Subgroup Discovery in Clinical Data Analysis - An Application to the International Diabetes Management Practice Study.
    Esnault C; Gadonna ML; Queyrel M; Templier A; Zucker JD
    Front Artif Intell; 2020; 3():559927. PubMed ID: 33733209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.